Author:
Harasymowycz Paul J,Papamatheakis Demosthenes G,Ennis Marguerite,Brady Mary,Gordon Keith D
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference31 articles.
1. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma.;Friedman;Am J Ophthalmol,2004
2. the XLT study group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized masked-evaluator multicenter study.;Parrish;Am J Ophthalmol,2003
3. The mechanism of action of prostaglandins on uveoscleral outflow.;Schachtschabel;Curr Opin Ophthalmol,2000
4. Topical prostaglandin F2a treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.;Sagara;Arch Ophthalmol,1999
5. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.;Sharif;J Ocul Pharmacol Ther,2003
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献